Case of linear porokeratosis: Successful treatment with topical 5% imiquimod cream [1]

Journal of Dermatology

Volumn 34, Issue 2, 2007, Pages 146-147

  Ahn, Soo Jin ^a   Lee, Hyun Ju ^a   Chang, Sung Eun ^a   Lee, Mi Woo ^a   Choi, Jee Ho ^a   Moon, Kee Chan ^a   Koh, Jai Kyoung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DESONIDE; IMIQUIMOD;

CASE REPORT; DRUG WITHDRAWAL; FOLLOW UP; HISTOLOGY; HUMAN; HYPOPIGMENTATION; INFLAMMATION; LETTER; MALE; PAPULE; POROKERATOSIS; PRESCHOOL CHILD; SKIN ATROPHY; SKIN IRRITATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AMINOQUINOLINES; CHILD; HUMANS; MALE; POROKERATOSIS;

EID: 33846194611     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2006.00236.x     Document Type: Letter

References (5)

1. Reed RJ, Reone P. Porokeratosis-a mutant clonal keratosis of the epidermis. Arch Dermatol 1970; 101: 340-347.
2. Schamroth JM, Zlotogorski A, Gilead L. Porokeratosis of Mibelli: overview and review of the literature. Acta Derm Venereol 1997; 77: 207-213.
3. Berman B, Poochareon VN, Villa AM. Novel dermatologic uses of the immune response modifier imiquimod 5% cream. Skin Therapy Lett 2002; 7: 1-6.
4. Agarwal S, Berth-Jones J. Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream. Br J Dermatol 2002; 146: 338-339.
5. Harrison S, Sinclair R. Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream. Australas J Dermatol 2003; 44: 281-283.